Seres Therapeutics, Inc. (MCRB) stock
MCRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.44+0.03 (+2.13%)
Close on Nov 18, 2026Market cap $14.32MP/E –Yield –
Seres Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Seres Therapeutics's market cap was $14.74M on Nov 11, 2026, against $157.68M a year earlier. Over the last 5 years it ranged from $14.74M to $817.84M, with a median of $153.95M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $14.74M | -88.7% |
| 2025 | Dec 31, 2025 | $130.42M | -7.8% |
| 2024 | Dec 31, 2024 | $141.44M | -21.5% |
| 2023 | Dec 29, 2023 | $180.08M | -74.2% |
| 2022 | Dec 30, 2022 | $696.70M | -8.9% |
| 2021 | Dec 31, 2021 | $765.04M | -65.8% |
| 2020 | Dec 31, 2020 | $2.23B | +825.4% |
| 2019 | Dec 31, 2019 | $241.48M | +30.8% |
| 2018 | Dec 31, 2018 | $184.62M | -55.1% |
| 2017 | Dec 29, 2017 | $410.80M | +2.8% |
| 2016 | Dec 30, 2016 | $399.52M | -70.8% |
| 2015 | Dec 31, 2015 | $1.37B | – |
See a number that looks wrong?